Journal article
A short-term in vivo model for giant cell tumor of bone.
- Abstract:
- BACKGROUND: Because of the lack of suitable in vivo models of giant cell tumor of bone (GCT), little is known about its underlying fundamental pro-tumoral events, such as tumor growth, invasion, angiogenesis and metastasis. There is no existing cell line that contains all the cell and tissue tumor components of GCT and thus in vitro testing of anti-tumor agents on GCT is not possible. In this study we have characterized a new method of growing a GCT tumor on a chick chorio-allantoic membrane (CAM) for this purpose. METHODS: Fresh tumor tissue was obtained from 10 patients and homogenized. The suspension was grafted onto the CAM at day 10 of development. The growth process was monitored by daily observation and photo documentation using in vivo biomicroscopy. After 6 days, samples were fixed and further analyzed using standard histology (hematoxylin and eosin stains), Ki67 staining and fluorescence in situ hybridization (FISH). RESULTS: The suspension of all 10 patients formed solid tumors when grafted on the CAM. In vivo microscopy and standard histology revealed a rich vascularization of the tumors. The tumors were composed of the typical components of GCT, including (CD51+/CD68+) multinucleated giant cells which were generally less numerous and contained fewer nuclei than in the original tumors. Ki67 staining revealed a very low proliferation rate. The FISH demonstrated that the tumors were composed of human cells interspersed with chick-derived capillaries. CONCLUSIONS: A reliable protocol for grafting of human GCT onto the chick chorio-allantoic membrane is established. This is the first in vivo model for giant cell tumors of bone which opens new perspectives to study this disease and to test new therapeutical agents.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 6.1MB, Terms of use)
-
(Version of record, zip, 32.8MB, Terms of use)
-
- Publisher copy:
- 10.1186/1471-2407-11-241
Authors
- Publisher:
- BioMed Central
- Journal:
- BMC Cancer More from this journal
- Volume:
- 11
- Issue:
- 1
- Article number:
- 241
- Publication date:
- 2011-01-01
- DOI:
- EISSN:
-
1471-2407
- ISSN:
-
1471-2407
- Language:
-
English
- Keywords:
- Subjects:
- Pubs id:
-
164315
- UUID:
-
uuid:0483cb8d-8a18-49e0-925a-b90471b32485
- Local pid:
-
pubs:164315
- Source identifiers:
-
164315
- Deposit date:
-
2013-11-17
- ARK identifier:
Terms of use
- Copyright holder:
- Balke et al
- Copyright date:
- 2011
- Notes:
- © 2011 Balke et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record